Development of a Novel Biomarker for Liver Fibrosis
NCT02348814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2019-04-17
Summary
The overall aim of this study is to validate a quantitative digital tool for staging liver fibrosis in biopsies from chronic human liver diseases and then evaluate it prospectively in patients.
Conditions
- Liver Fibrosis
Sponsors & Collaborators
-
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Simon Beaven, MD/PhD · UCLA Dept of Medicine, Division of Digestive Diseases
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2019-01-26
- Completion
- 2019-02-26
Countries
- United States
Study Locations
More Related Trials
-
Establishment of NAFLD Cohort and Development of Fibrosis Markers
NCT02206841 ·Status: RECRUITING
-
Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
NCT01600105 ·Status: COMPLETED ·Phase: PHASE4
-
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
Methods to Detect Liver Fibrosis
NCT03027700 ·Status: TERMINATED ·Phase: NA
-
Identification of Hepatic Fibrosis Using 4D-MRI
NCT05385237 ·Status: RECRUITING ·Phase: NA
-
Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver Enzymes
NCT01784484 ·Status: UNKNOWN
-
Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation
NCT05168982 ·Status: COMPLETED
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
NCT06779058 ·Status: RECRUITING
-
Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression
NCT02267148 ·Status: COMPLETED
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Hepatic Fibrosis Non-invasive Methods Questionnaire
NCT02132351 ·Status: COMPLETED
-
Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis
NCT01572064 ·Status: COMPLETED ·Phase: NA
-
Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver Fibrosis
NCT01268865 ·Status: UNKNOWN
-
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
NCT01825213 ·Status: COMPLETED
-
Biomarkers in the Diagnosis and Prognosis of NAFLD
NCT06098417 ·Status: RECRUITING
-
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
NCT00373347 ·Status: COMPLETED
-
Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy
NCT01246388 ·Status: UNKNOWN
-
A Study to Evaluate Liver Stiffness With Shear Wave Elastography
NCT05097963 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test
NCT05108415 ·Status: UNKNOWN
-
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease
NCT01360879 ·Status: UNKNOWN
-
Real Time Elastography in Liver Fibrosis
NCT01948687 ·Status: UNKNOWN
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA